Display options
Share it on

World J Hepatol. 2016 Jul 08;8(19):796-814. doi: 10.4254/wjh.v8.i19.796.

Assembly and release of infectious hepatitis C virus involving unusual organization of the secretory pathway.

World journal of hepatology

Miriam Triyatni, Edward A Berger, Bertrand Saunier

Affiliations

  1. Miriam Triyatni, Roche Innovation Center, Roche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland.

PMID: 27429716 PMCID: PMC4937168 DOI: 10.4254/wjh.v8.i19.796

Abstract

AIM: To determine if calnexin (CANX), RAB1 and alpha-tubulin were involved in the production of hepatitis C virus (HCV) particles by baby hamster kidney-West Nile virus (BHK-WNV) cells.

METHODS: Using a siRNA-based approach complemented with immuno-fluorescence confocal microscope and Western blot studies, we examined the roles of CANX, RAB1 and alpha-tubulin in the production of HCV particles by permissive BHK-WNV cells expressing HCV structural proteins or the full-length genome of HCV genotype 1a. Immuno-fluorescence studies in producer cells were performed with monoclonal antibodies against HCV structural proteins, as well as immunoglobulin from the serum of a patient recently cured from an HCV infection of same genotype. The cellular compartment stained by the serum immunoglobulin was also observed in thin section transmission electron microscopy. These findings were compared with the JFH-1 strain/Huh-7.5 cell model.

RESULTS: We found that CANX was necessary for the production of HCV particles by BHK-WNV cells. This process involved the recruitment of a subset of HCV proteins, detected by immunoglobulin of an HCV-cured patient, in a compartment of rearranged membranes bypassing the endoplasmic reticulum-Golgi intermediary compartment and surrounded by mitochondria. It also involved the maturation of N-linked glycans on HCV envelope proteins, which was required for assembly and/or secretion of HCV particles. The formation of this specialized compartment required RAB1; upon expression of HCV structural genes, this compartment developed large vesicles with viral particles. RAB1 and alpha-tubulin were required for the release of HCV particles. These cellular factors were also involved in the production of HCVcc in the JFH-1 strain/Huh-7.5 cell system, which involves HCV RNA replication. The secretion of HCV particles by BHK-WNV cells presents similarities with a pathway involving caspase-1; a caspase-1 inhibitor was found to suppress the production of HCV particles from a full-length genome.

CONCLUSION: Prior activity of the WNV subgenomic replicon in BHK-21 cells promoted re-wiring of host factors for the assembly and release of infectious HCV in a caspase-1-dependent mechanism.

Keywords: Flavivirus replicon; Hepatitis C virus; Host cellular factors; Membrane rearrangements; Virus assembly and secretion

References

  1. J Virol. 2012 Jun;86(12):6491-502 - PubMed
  2. Hepatology. 2011 Oct;54(4):1149-56 - PubMed
  3. J Virol. 1996 Feb;70(2):778-86 - PubMed
  4. J Virol. 2002 Sep;76(18):9335-44 - PubMed
  5. Eur J Immunol. 2004 Oct;34(10):2834-42 - PubMed
  6. J Virol. 2015 Mar;89(5):2956-61 - PubMed
  7. PLoS Pathog. 2014 Oct 02;10(10):e1004424 - PubMed
  8. PLoS One. 2014 Dec 01;9(12):e113034 - PubMed
  9. Cell Microbiol. 2013 Jan;15(1):24-34 - PubMed
  10. Trends Microbiol. 2011 Feb;19(2):95-103 - PubMed
  11. Science. 2015 Jul 10;349(6244):195-8 - PubMed
  12. Annu Rev Biochem. 2004;73:1019-49 - PubMed
  13. Nat Rev Microbiol. 2013 Oct;11(10):688-700 - PubMed
  14. Biochim Biophys Acta. 2014 Apr;1837(4):461-9 - PubMed
  15. EMBO J. 2009 Apr 22;28(8):1016-28 - PubMed
  16. J Virol. 2010 Nov;84(21):10999-1009 - PubMed
  17. Cytokine. 2015 Aug;74(2):213-8 - PubMed
  18. Science. 1997 Jul 25;277(5325):570-4 - PubMed
  19. J Virol. 2008 Aug;82(15):7624-39 - PubMed
  20. Virology. 2006 Mar 1;346(1):53-65 - PubMed
  21. Science. 1998 Jul 10;281(5374):269-72 - PubMed
  22. PLoS Pathog. 2009 Mar;5(3):e1000339 - PubMed
  23. Science. 2000 Jul 21;289(5478):444-8 - PubMed
  24. J Virol. 2014 Feb;88(3):1433-46 - PubMed
  25. Traffic. 2010 May;11(5):616-25 - PubMed
  26. Hepatology. 2015 Nov;62(5):1346-52 - PubMed
  27. Viruses. 2015 Jun 19;7(6):3204-25 - PubMed
  28. Cell Logist. 2014 Jan 09;3:e27687 - PubMed
  29. J Cell Sci. 2010 Jul 1;123(Pt 13):2273-80 - PubMed
  30. J Cell Biol. 2011 Nov 14;195(4):605-15 - PubMed
  31. J Biol Chem. 2005 Jun 17;280(24):23349-55 - PubMed
  32. Science. 1999 Jul 2;285(5424):110-3 - PubMed
  33. J Virol. 2010 Jan;84(2):773-87 - PubMed
  34. PLoS Pathog. 2009 Jun;5(6):e1000475 - PubMed
  35. Sci Rep. 2014 Dec 08;4:7357 - PubMed
  36. Cell. 2009 Aug 7;138(3):549-61 - PubMed
  37. Nat Rev Microbiol. 2008 Sep;6(9):699-708 - PubMed
  38. Lancet Infect Dis. 2005 Sep;5(9):558-67 - PubMed
  39. J Virol. 2006 Mar;80(6):2832-41 - PubMed
  40. Proc Natl Acad Sci U S A. 2009 May 5;106(18):7577-82 - PubMed
  41. Cell Host Microbe. 2009 Apr 23;5(4):365-75 - PubMed
  42. World J Gastroenterol. 2016 Feb 14;22(6):1953-65 - PubMed
  43. J Virol. 2007 Aug;81(16):8374-83 - PubMed
  44. Mol Biol Cell. 2006 Aug;17(8):3494-507 - PubMed
  45. J Gen Virol. 2001 Aug;82(Pt 8):1877-83 - PubMed
  46. Proc Natl Acad Sci U S A. 1980 Feb;77(2):780-4 - PubMed
  47. PLoS Pathog. 2015 Sep 25;11(9):e1005185 - PubMed
  48. Lancet. 2015 Mar 21;385(9973):1124-35 - PubMed
  49. Nature. 2009 Aug 20;460(7258):978-83 - PubMed
  50. Nat Rev Mol Cell Biol. 2009 Feb;10(2):148-55 - PubMed
  51. Cell Mol Life Sci. 2002 Jan;59(1):112-25 - PubMed
  52. PLoS Pathog. 2009 Oct;5(10):e1000632 - PubMed
  53. Nat Med. 2005 May;11(5):522-30 - PubMed
  54. Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14590-5 - PubMed
  55. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3805-9 - PubMed
  56. Gastroenterology. 2010 Nov;139(5):1774-83, 1783.e1-6 - PubMed
  57. Hepatology. 2007 Aug;46(2):330-8 - PubMed
  58. PLoS Pathog. 2011 Jul;7(7):e1002144 - PubMed
  59. Nat Cell Biol. 2007 Sep;9(9):1089-97 - PubMed
  60. Curr Opin Microbiol. 2014 Aug;20:1-9 - PubMed
  61. J Virol. 2004 Jul;78(14):7737-47 - PubMed
  62. J Clin Invest. 2010 Mar;120(3):650-3 - PubMed
  63. J Viral Hepat. 2013 Jun;20(6):369-76 - PubMed
  64. J Hepatol. 2014 Nov;61(1 Suppl):S34-44 - PubMed
  65. J Virol. 2008 Nov;82(21):10519-31 - PubMed
  66. PLoS Pathog. 2007 Aug 31;3(8):e108 - PubMed
  67. Hepatology. 2012 Sep;56(3):861-72 - PubMed
  68. Sci Rep. 2015 Jul 10;5:10592 - PubMed
  69. PLoS Pathog. 2011 Apr;7(4):e1001333 - PubMed
  70. Mol Syst Biol. 2008;4:230 - PubMed
  71. Cell Host Microbe. 2007 Oct 11;2(4):229-39 - PubMed
  72. J Virol. 2006 Nov;80(22):11074-81 - PubMed
  73. BMJ. 2014 Jul 07;348:g3308 - PubMed
  74. Glycobiology. 2013 Apr;23(4):453-74 - PubMed
  75. J Virol. 2003 Jan;77(1):546-59 - PubMed
  76. Nat Commun. 2014 Sep 16;5:4874 - PubMed
  77. Cell Host Microbe. 2013 Nov 13;14(5):522-34 - PubMed
  78. Cold Spring Harb Perspect Biol. 2014 Oct 16;6(12 ):a016287 - PubMed
  79. Nat Med. 2005 Jul;11(7):791-6 - PubMed
  80. J Biol Chem. 2009 May 15;284(20):13778-91 - PubMed
  81. J Virol. 2002 Jul;76(14):6919-28 - PubMed
  82. J Virol. 2003 Mar;77(5):3181-90 - PubMed
  83. Lancet Infect Dis. 2015 Apr;15(4):451-60 - PubMed

Publication Types

Grant support